Back

Optum Health Education

  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Obesity
  • Obesity Management

Redefining Obesity and Diabetes Care: GLP-1 Agonists in Clinical Practice

This activity will address the latest breakthroughs in obesity management, with a focus on glucagon-like peptide 1 (GLP-1) agonists and their role in combating obesity and associated diseases such as diabetes. It will cover these agonists mechanisms of action, their benefits in weight reduction and cardiovascular risk mitigation. Strategies for integrating these medications into treatment protocols and criteria for patient selection will also be discussed, as well as the challenges related to accessibility and insurance coverage for these therapies.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 creditPsychologyUp to 1 creditSocial WorkUp to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • Released
    Dec 9, 2024
  • Last day to claim credit
    Dec 10, 2027 1 year left